Related Experiment Video
Updated: May 19, 2026
09:04
DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
Nutrigenomics and nutrigenetics in inflammatory bowel diseases
Lisa Gruber1, Pia Lichti, Eva Rath
1Technische Universität München, ZIEL-Research Center for Nutrition and Food Science, Center for Diet and Disease, Freising-Weihenstephan, Germany.
Journal of Clinical Gastroenterology
|September 4, 2012
Summary
Inflammatory bowel diseases (IBD) involve complex gene-environment interactions. Nutrigenetics and nutrigenomics offer new ways to understand nutrient-gene links for personalized IBD prevention and treatment.
Area of Science:
- Gastroenterology and Immunology
- Nutritional Science
- Genetics
Background:
- Inflammatory bowel diseases (IBD), including ulcerative colitis and Crohn's disease, are chronic immune-mediated disorders.
- IBD pathogenesis involves a complex interplay of genetic predisposition and environmental factors like diet and gut microbiota.
- Current understanding of IBD etiology is challenged by its heterogeneous nature and controversial epidemiological data on dietary links.
Purpose of the Study:
- To review the impact of nutrients on intestinal inflammation.
- To highlight the role of nutrient-gene interactions in IBD.
- To explore the potential of "omic" technologies in IBD research.
Main Methods:
- Review of existing scientific literature on IBD, nutrition, and genetics.
- Discussion of "nutrigenetics" and "nutrigenomics" principles.
- Exploration of high-throughput "omic" technologies.
Main Results:
- Genetic factors (identified via GWAS) and environmental factors significantly contribute to IBD development.
- Nutrient-gene interactions are crucial but complex, with epidemiological data showing varied outcomes.
- "Omic" technologies offer a systems-level approach to study these interactions.
Conclusions:
- Integrating nutrigenetics and nutrigenomics is essential for understanding gene-environment interactions in IBD.
- Personalized nutrition strategies hold promise for IBD prevention and treatment.
- "Omic" approaches can advance patient stratification and therapeutic development for IBD.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...